Changing global essential medicines norms to improve access to AIDS treatment: Lessons from Brazil

Global trade and access to medicines: AIDS treatments in Thailand.

pharmaceutical strategic purchasing: a key to improve access to medicines

pharmaceuticals are often considered as the most significant cost driver of health care expenditures and at the same time have a major impact on patients’ curative processes and outcomes. other pieces of evidence emphasize that drugs are the input for the production of good health. they are considered as the most important and expensive element in the healthy supply chain and are more associate...

Patently necessary: improving global access to essential medicines.

Lessons From Zika Policies to Improve Gender Equity

Gender equity is easily supported in theory but harder to pursue in practice. In this article, the case of Zika travel policies is used to illustrate some glaring gaps related to gender, for both men and women, at both international and national levels. Zika travel policies have not considered new evidence on biological or social determinants of health, putting babies at risk of exposure. The a...

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

BACKGROUND Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited financing, and few fixed-dose combination (FDC) products. Global initiatives aim to promote efficient global ARV markets, yet little is known about m...